In our study, Type I IFN and Type II IFN were proven to be significantly correlated with endometrial cancer, indicating that targeting type I and II IFN into a special cellular compartment of endometrial cancer might manage to play an optimal therapeutic role. This evidence concerns the gene IFNA1 and endometrial cancer.